Related references
Note: Only part of the references are listed.Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease
M. A. Smith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease
L. J. J. Derijks et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease
M. Daperno et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease
M. A. Smith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle
H. Sokol et al.
GUT (2009)
Incidence and Clinical Significance of Immunogenicity to Infliximab in Crohn's Disease: A Critical Systematic Review
Andrea Cassinotti et al.
INFLAMMATORY BOWEL DISEASES (2009)
Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease
Yvette Leung et al.
JOURNAL OF CROHNS & COLITIS (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine
Ahmed F. Hawwa et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold
Sharon J. Gardiner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Initial Clinical Experience with Allopurinol-Thiopurine Combination Therapy in Pediatric Inflammatory Bowel Disease
Riad M. Rahhal et al.
INFLAMMATORY BOWEL DISEASES (2008)
European evidence-based Consensus on the management of ulcerative colitis: Current management
S. P. L. Travis et al.
JOURNAL OF CROHNS & COLITIS (2008)
Crohn's disease: beyond antagonists of tumour necrosis factor
Laurent Peyrin-Biroulet et al.
LANCET (2008)
Functional characterization of human xanthine oxidase allelic variants
Mutsumi Kudo et al.
PHARMACOGENETICS AND GENOMICS (2008)
Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity
Rebecca L. Roberts et al.
PHARMACOGENETICS AND GENOMICS (2008)
The role of xanthine oxidase in thiopurine metabolism: A case report
Dennis R. Wong et al.
THERAPEUTIC DRUG MONITORING (2007)
Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism
Nanne K. H. de Boer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
G. Vernier-Massouille et al.
GUT (2007)
Adherence to thiopurine treatment in out-patients with Crohn's disease
B. Bokemeyer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease:: results from a randomized, controlled, open trial
Max Reinshagen et al.
CLINICAL CHEMISTRY (2007)
How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission?
Gerassimos J. Mantzaris et al.
INFLAMMATORY BOWEL DISEASES (2007)
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine
Miles P. Sparrow et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
U. Hindorf et al.
GUT (2006)
Two cases of thiopurine methyltransferase (TPMT) deficiency - a lucky save and a near miss with azathioprine
Sharon J. Gardiner et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
MT Osterman et al.
GASTROENTEROLOGY (2006)
5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
S Hande et al.
INFLAMMATORY BOWEL DISEASES (2006)
American Gastroenterological Association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
GR Lichtenstein et al.
GASTROENTEROLOGY (2006)
Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice
RB Gearry et al.
INTERNAL MEDICINE JOURNAL (2005)
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine
MP Sparrow et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
RB Gearry et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
6-Tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine
X Roblin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
AM Marinaki et al.
PHARMACOGENETICS (2004)
Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine
RB Gearry et al.
PHARMACOGENETICS (2004)
Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas
NACS Wong et al.
JOURNAL OF PATHOLOGY (2003)
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients
MC Dubinsky et al.
GASTROENTEROLOGY (2003)
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine
AG Fraser et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2002)
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
PW Lowry et al.
GUT (2001)
Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease
J Belaiche et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
RJ Farrell et al.
GUT (2000)
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
JF Colombel et al.
GASTROENTEROLOGY (2000)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)
Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease - Association with inflammatory bowel disease and immunosuppression
S Kumar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Share Paper
